Symphony Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Symphony Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,133	Closed	-$798K	–	453
2015 Q3	$798K	Buy	14,133 +1,037	+8%	+$67.2K	0.1%	227
2015 Q2	$774K	Sell	13,096 -8,893	-40%	-$549K	0.1%	212
2015 Q1	$1.37M	Buy	21,989 +12,800	+139%	+$744K	0.16%	136
2014 Q4	$528K	Sell	9,189 -232	-2%	-$12.9K	0.07%	240
2014 Q3	$506K	Sell	9,421 -226	-2%	-$12K	0.05%	252
2014 Q2	$506K	Sell	9,647 -332	-3%	-$17K	0.05%	315
2014 Q1	$527K	Sell	9,979 -6,049	-38%	-$280K	0.05%	300
2013 Q4	$643K	Buy	+16,028	New	+$631K	0.05%	249

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Symphony Asset Management's TEVA Position: Q4 2015 in Review

Symphony Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2015, closing a stake of 14,133 shares — an estimated $798K sold.

Symphony Asset Management first reported a position in TEVA in Q4 2013 and held it in 8 quarters. The position peaked at $1.37M in Q1 2015. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Symphony Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2015 after selling out during the quarter.
Symphony Asset Management sold 14,133 Teva Pharmaceutical Industries Limited shares in Q4 2015, an estimated $798K.
Symphony Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 8 quarters.
Symphony Asset Management's Teva Pharmaceutical Industries Limited position peaked at $1.37M in Q1 2015.
877 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2015.

Based on Symphony Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.